Nobivac^® Parvo-C Questions and Answers

For active immunisation of dogs to prevent mortality, clinical signs and viral excretion following canine parvovirus infection.

The onset of immunity is 1 week following vaccination.

Where earlier protection is required a first dose may be given to puppies from 4 weeks of age, but because maternally derived passive antibody can interfere with the response to vaccination a final dose at 10 weeks of age or older is generally recommended.

The duration of immunity is expected to last at least 3 years.

It is recommended that dogs are revaccinated against canine parvovirus every 3 years.

Yes, it can be used in pregnant bitches which have previously been vaccinated with the CPV (strain 154) antigens included in the Nobivac vaccine series.

We do not hold specific data regarding use during lactation and therefore cannot recommend this use during this period.

Nobivac Parvo-C requires storage in a refrigerator between 2 ^oC and 8 ^oC. Do not freeze. Protect from light.

Care should be taken to avoid prolonged or repetitive exposure to high ambient temperatures following withdrawal from the refrigerator prior to use - in hot summer conditions vaccine potency can be severely reduced within a few hours.

There are no breed-specific contraindications for Nobivac Parvo-C.

Safety and efficacy data are available which demonstrate that this vaccine can be mixed and administered with the inactivated vaccines of the Nobivac series for subcutaneous administration against canine leptospirosis caused by all or some of the following serovars: L. interrogans serogroup Canicola serovar Canicola, L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni, L. interrogans serogroup Australis serovar Bratislava, and L. kirschneri serogroup Grippotyphosa serovar Bananal/Liangguang.

Safety and efficacy data are available which demonstrate that this vaccine can be administered at the same time but not mixed with the inactivated vaccine of the Nobivac range against Bordetella bronchiseptica.

Safety and efficacy data are available which demonstrate that this vaccine can be mixed and administered with Nobivac^® Rabies.

Where earlier protection is required a first dose may be given to puppies from 4 weeks of age, but because maternally derived passive antibody can interfere with the response to vaccination a final dose at 10 weeks of age or older is generally recommended.

A single injection should establish active immunity to disease caused by canine parvovirus infection in dogs of 10 weeks of age or older.

To reconstitute freeze dried small animal Nobivac vaccines which include instructions to be reconstituted with Nobivac Solvent.

Nobivac Solvent requires storage not exceeding 25 °C and protected from light. Do not freeze.

Shelf life of the veterinary medicinal product as packaged for sale: 2 years

* Nobivac FeLV is presented as a suspension for injection therefore does not require reconsitution.

Each vaccine is formulated on the basis of a minimum immunising dose, not a dose per body weight. Therefore the full vaccine dose/reconstituted amount is the minimal immunising dose.

In order for the product shelf-life to be as it is stated on the product's SPC it should be stored as per the datasheet's storage requirements. This will always be our recommendation for product use.

In the case of any doubt it would be advisable to contact the Technical Product Support team before discarding any product.

In the event where it is advisable to discard product it may be possible to claim on the practice's insurance. Our Technical Product Support team can write a letter of support for insurance claims, pertaining to deviations in storage conditions, should you require it.